You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

resectable esophageal

Showing 1 - 25 of 3,585
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Aug 16, 2023

Immunotherapy;Envafolimab; Esophageal Cancer Trial (Envafolimab, Abraxane, Cisplatin)

Not yet recruiting
  • Immunotherapy;Envafolimab; Esophageal Cancer
  • (no location specified)
Apr 24, 2023

Sintilimab and Anlotinib in Combination With Chemo Trial in Xi'an (Sintilimab and anlotinib in combination with chemo)

Completed
  • Sintilimab and Anlotinib in Combination With Chemotherapy
  • Sintilimab and anlotinib in combination with chemotherapy
  • Xi'an, Shanxi, China
  • +1 more
Aug 27, 2023

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy Trial (neoadjuvant anti-PD-1 (Keytruda) plus chemo)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Chemoimmunotherapy
  • neoadjuvant anti-PD-1 (Keytruda) plus chemotherapy
  • (no location specified)
Feb 14, 2023

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)

Recruiting
  • Neoadjuvent
  • +3 more
  • Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
  • Xi'an, Shaanxi, China
  • +2 more
Aug 17, 2023

Esophageal Squamous Cell Carcinoma Trial (Envafolimab, Albumin-Bound Paclitaxel, Carboplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • (no location specified)
Sep 21, 2022

Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Hangzhou (Serplulimab, Albumin paclitaxel, carboplatin AUC=5,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Therapy
  • Serplulimab, Albumin paclitaxel, carboplatin AUC=5, neoadjuvant therapy
  • Esophagectomy
  • Hangzhou, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 20, 2022

Esophageal Cancer Trial (Blood sample)

Not yet recruiting
  • Esophageal Cancer
  • Blood sample
  • (no location specified)
Jan 19, 2023

Resectable Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial (cadonilimab+chemo)

Not yet recruiting
  • Resectable Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Apr 18, 2023

Esophageal Cancer, Surgery, Neoadjuvant Treatment Trial in Zhengzhou (Neoadjuvant immunochemo)

Recruiting
  • Esophageal Cancer
  • +3 more
  • Neoadjuvant immunochemotherapy
  • Zhengzhou, Henan, China
    Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
Oct 2, 2022

Esophageal Squamous Cell Carcinoma Trial in Nanjing (Sintilimab, Liposomal Paclitaxel + Cisplatin + S-1)

Active, not recruiting
  • Esophageal Squamous Cell Carcinoma
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jul 16, 2022

Resectable Esophageal Cancer, GastroEsophageal Cancer Trial in Madison (combination product, drug, radiation)

Active, not recruiting
  • Resectable Esophageal Cancer
  • GastroEsophageal Cancer
  • Avelumab combined with Chemoradiation
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Mar 28, 2022

Esophageal Adenocarcinoma Trial in Mainz (Minimally invasive esophagectomy, daVinci Xi system)

Recruiting
  • Esophageal Adenocarcinoma
  • Minimally invasive esophagectomy
  • daVinci Xi system
  • Mainz, Germany
    University Medical Center Mainz
May 16, 2022

Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States

Not yet recruiting
  • Esophageal Adenocarcinoma
  • +2 more
  • Palo Alto, California
  • +5 more
Jan 12, 2023

Esophageal Squamous Cell Carcinoma Trial in Hanzhou, Ningbo (Neoadjuvant Radiotherapy, Neoadjuvant Chemotherapy, Immunotherapy)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Radiotherapy
  • +2 more
  • Hanzhou, Zhejiang, China
  • +2 more
Aug 16, 2022

Advanced Esophageal Squamous Cell Cancer Trial in Jinan (Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy)

Recruiting
  • Advanced Esophageal Squamous Cell Cancer
  • Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy
  • Jinan, Shandong, China
    Shandong Cancer Hospital and Institute
Apr 11, 2022

Esophageal Squamous Cell Carcinoma Trial in Tokyo (FLOT therapy)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • FLOT therapy
  • Tokyo, Japan
    Keio University Hospital
Aug 15, 2022

Esophageal Cancer Trial (SDD)

Not yet recruiting
  • Esophageal Cancer
  • (no location specified)
May 9, 2023

Resectable Esophageal Squamous Cell Carcinoma Trial (SHR-1210)

Not yet recruiting
  • Resectable Esophageal Squamous Cell Carcinoma
  • (no location specified)
Aug 17, 2021

Resectable Esophageal Squamous Cell Carcinoma Trial in China (Tislelizumab)

Recruiting
  • Resectable Esophageal Squamous Cell Carcinoma
  • Hefei, Anhui, China
  • +7 more
Feb 23, 2022

The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

Recruiting
  • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
  • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
  • Hanzhou, Zhejiang, China
    Lulu Liu
Jul 14, 2023

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai chest hospital
Sep 24, 2023

Esophageal Squamous Cell Carcinoma, Oligometastatic Disease Trial in Beijing (Esophagectomy)

Active, not recruiting
  • Esophageal Squamous Cell Carcinoma
  • Oligometastatic Disease
  • Esophagectomy
  • Beijing, China
  • +1 more
Jul 11, 2023

Esophagus Cancer Trial in Loma Linda (Proton radiation)

Recruiting
  • Esophagus Cancer
  • Proton radiation
  • Loma Linda, California
    Loma Linda University Medical Center
Feb 16, 2022